CLINICAL_TRIALS
trial_result
· 2024-10-15
Clinical Trial Update: Performance of the Travoprost Intraocular Implant [Phase 2]
Summary
Phase 2 trial results for the travoprost intraocular implant targeting open-angle glaucoma and ocular hypertension have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Glaukos Corporation | Conditions: Glaucoma, Open-Angle, Ocular Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2024-10-15